Abstract:Background:Oily skin is one of the most common dermatological complaints. Oily skin may be accompanied by enlarged pores, acne, and seborrheic dermatitis.Moreover, oily skin has negative effects on self-perception. Most therapeutic approaches used to treat oily skin have had varying degrees of efficacy and include topical treatments, such as photodynamic therapy and lasers. However, certain of these therapies for oily skin may lead to severe side effects. With the expanding use and high safety profile of botul… Show more
“…No standardized approaches nor agents have proven effective for the treatment of seborrhea. Current available treatments that can reduce sebum include topical drugs, systemic treatments, botulinum toxin injection, and phototherapy . Exact mechanisms of action of some treatments are still unclear, but various mechanisms have been proposed, with ultimate outcomes being sebosuppression via reducing sebocyte proliferation, differentiation, and apoptosis .…”
Background
Seborrhea is linked to several medical and mental conditions. Although it is common, effective agents and the standardized sebum level for seborrhea are not elucidated.
Aims
To determine the efficacy of chitosan particles (CP) formulation on controlling sebum secretion, its extended effects on skin redness and texture after combining with proretinal nanoparticles (CP‐PRN), and a correlation of the clinical grading with sebum levels that affect mental health.
Patients/Methods
A four‐week clinical trial with forty subjects was conducted. Subjects applied either CP formulation or CP‐PRN during nighttime. Objective measurements including sebum levels, transepidermal water loss (TEWL), skin corneometry, skin redness, and texture were analyzed. Subjects completed a self‐assessment clinical grading of skin oiliness at every visit.
Results
Both CP and CP‐PRN significantly decreased sebum levels (P ≤ .01) at week 4 compared to baseline. CP also resulted in significant decreases in TEWL (P ≤ .05) and skin corneometry (P ≤ .05) throughout the study. A significant improvement in skin redness was observed with CP‐PRN (P ≤ .01). A moderate correlation between the clinical grading and sebum levels was detected (coefficient of 0.5, P ≤ .001), with a sebum level of 106 μg cm‐2 indicating emotional discomfort. One subject experienced local irritation with the CP‐PRN. Mild pruritic symptoms were reported in both groups.
Conclusions
Chitosan particles exhibited an interesting anti‐sebum effect. It could be combined with PRN to extend benefits without losing the sebum controlling effect. The clinical grading may be useful in practice due to a modest correlation with sebum levels.
“…No standardized approaches nor agents have proven effective for the treatment of seborrhea. Current available treatments that can reduce sebum include topical drugs, systemic treatments, botulinum toxin injection, and phototherapy . Exact mechanisms of action of some treatments are still unclear, but various mechanisms have been proposed, with ultimate outcomes being sebosuppression via reducing sebocyte proliferation, differentiation, and apoptosis .…”
Background
Seborrhea is linked to several medical and mental conditions. Although it is common, effective agents and the standardized sebum level for seborrhea are not elucidated.
Aims
To determine the efficacy of chitosan particles (CP) formulation on controlling sebum secretion, its extended effects on skin redness and texture after combining with proretinal nanoparticles (CP‐PRN), and a correlation of the clinical grading with sebum levels that affect mental health.
Patients/Methods
A four‐week clinical trial with forty subjects was conducted. Subjects applied either CP formulation or CP‐PRN during nighttime. Objective measurements including sebum levels, transepidermal water loss (TEWL), skin corneometry, skin redness, and texture were analyzed. Subjects completed a self‐assessment clinical grading of skin oiliness at every visit.
Results
Both CP and CP‐PRN significantly decreased sebum levels (P ≤ .01) at week 4 compared to baseline. CP also resulted in significant decreases in TEWL (P ≤ .05) and skin corneometry (P ≤ .05) throughout the study. A significant improvement in skin redness was observed with CP‐PRN (P ≤ .01). A moderate correlation between the clinical grading and sebum levels was detected (coefficient of 0.5, P ≤ .001), with a sebum level of 106 μg cm‐2 indicating emotional discomfort. One subject experienced local irritation with the CP‐PRN. Mild pruritic symptoms were reported in both groups.
Conclusions
Chitosan particles exhibited an interesting anti‐sebum effect. It could be combined with PRN to extend benefits without losing the sebum controlling effect. The clinical grading may be useful in practice due to a modest correlation with sebum levels.
“…5 More recently, intradermal injection of BTX has been used off-label for various aesthetic conditions, including facial skin laxity, excess sebum production, and enlarged facial pores. [8][9][10][11][12][13] These effects could be attributed to the paralysis of arrector pili muscles or decreased sebum production via acetylcholine inhibition. 10,13,14 However, previous studies relied on subjective evaluation and lacked long-term clinical data.…”
Background: Intradermal injections of botulinum toxin have been reported to improve sebum secretion, facial skin laxity, and facial pores. However, the effects of Incobotulinumtoxin-A for these indications have not been reported. Objective: To evaluate the efficacy of Incobotulinumtoxin-A for the improvement of sebum secretion, face laxity, and facial pores. Materials and Methods: This single-center retrospective study included patients treated with Incobotulinumtoxin-A to improve facial skin laxity, sebum secretion, and facial pores. The microdroplet injection protocol included injection points on the lateral face, anterior medial cheek, mandibular line, depressor anguli oris points, mid-glabella area, and chin. Outcomes were measured using a Sebumeter and three-dimensional scanner and were evaluated by facial laxity ratings and the Global Aesthetic Improvement Scale. Results: Twenty patients were included in the analysis. Sebum secretion, mandibular length, facial pores, and facial laxity ratings were improved at 1 week and results were sustained through 12 weeks. All outcomes showed maximum improvement after 4 weeks. Evaluation using the Global Aesthetic Improvement Scale showed that all subjects reported at least a score of 2 (improved) after 4 weeks. Conclusion: This study showed that intradermal injection with Incobotulinumtoxin-A could be effective for face lifting, reduced sebum production, and improved facial pores.
“…Intradermal injection of botulinum toxin is suggested as a new strategy for treating excessive sebum and enlarged pores . Rose et al reported that botulinum toxin treatment decreases sebum production to 80% after 1 month, which is comparable with the reported sebum reduction by oral isotretinoin (60%‐90%) .…”
Section: Management Recommendationsmentioning
confidence: 73%
“…It is usually accompanied by enlarged pores, acne, and seborrheic dermatitis. Moreover, oily skin has negative effects on self‐perception . Meanwhile, sensitive skin is described as a condition of subjective hyper‐reactivity to exogenous factors.…”
Background
Due to the ever‐increasing demands for the personalized care, people seek for the tailored management according to the accurate identification of their skin type. The Baumann Skin Type Indicator, which was proposed by Leslie Baumann, is composed of four parameters: oily or dry, resistant or sensitive, pigmented or nonpigmented, and wrinkled or tight. Among these, oily sensitive skin experiences significant discomfort and resists ordinary treatment.
Aims
In this article, we will review the clinical manifestations, underlying pathogenesis and recommendations on treatment options that may be utilized to help patients with oily sensitive skin.
Patients/Methods
Literature search was conducted using PubMed. The literature concerning Baumann Skin Type Indicator and oily sensitive skin type were considered.
Results
Oily sensitive (OS)‐type skin is a complex of oily and sensitive skin that causes significant discomfort and undergoes stubborn resistance to treatments. Sebum dysfunction and hypersensitivity may play a key role in the development of sensitive skin. Considering the pathogenesis of OS‐type skin, treatment should focus on both seborrhea and hypersensitivity.
Conclusion
Clinicians can effectively treat the oily sensitive skin by understanding underlying pathogenesis of it. Further investigations are necessary to reach a consensus on the basic pathophysiology and optimal management guidelines for oily sensitive skin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.